To investigate safety issues related to use of haploidentical highly purified CD133+ hematopoietic cells in patients with SCID [clinicaltrials_resource:d400bb4e57a0a51068353bb10691a563]

St. Jude Children's Research Hospital

To investigate safety issues related to use of haploidentical highly purified CD133+ hematopoietic cells in patients with SCID [clinicaltrials_resource:d400bb4e57a0a51068353bb10691a563]

St. Jude Children's Research Hospital